Item 16. Form 10-K Summary

8K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



MONDELĒZ INTERNATIONAL, INC.

By:						/s/ LUCA ZARAMELLA
						Luca Zaramella
						Executive Vice President
						and Chief Financial Officer
						(Duly Authorized Officer)

Date: February 5, 2021

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:


Signature	Title	Date

/s/ DIRK VAN DE PUT	Director, Chairman and Chief Executive Officer	February 5, 2021
(Dirk Van de Put)
/s/ LUCA ZARAMELLA	Executive Vice President and Chief Financial Officer	February 5, 2021
(Luca Zaramella)
/s/ NELSON URDANETA	Senior Vice President, Corporate Controller and Chief Accounting Officer	February 5, 2021
(Nelson Urdaneta)
/s/ LEWIS W.K. BOOTH	Director	February 5, 2021
(Lewis W.K. Booth)
/s/ CHARLES E. BUNCH	Director	February 5, 2021
(Charles E. Bunch)
/s/ DEBRA A. CREW	Director	February 5, 2021
(Debra A. Crew)
/s/ LOIS D. JULIBER	Director	February 5, 2021
(Lois D. Juliber)
/s/ PETER W. MAY	Director	February 5, 2021
(Peter W. May)
/s/ JORGE S. MESQUITA	Director	February 5, 2021
(Jorge S. Mesquita)
/s/ FREDRIC G. REYNOLDS	Director	February 5, 2021
(Fredric G. Reynolds)
/s/ CHRISTIANA S. SHI	Director	February 5, 2021
(Christiana S. Shi)
/s/ PATRICK T. SIEWERT	Director	February 5, 2021
(Patrick T. Siewert)
/s/ MICHAEL A. TODMAN	Director	February 5, 2021
(Michael A. Todman)
/s/ JEAN-FRANÇOIS M. L. VAN BOXMEER	Director	February 5, 2021
(Jean-François M. L. van Boxmeer)

Table of Contents

Mondelēz International, Inc. and Subsidiaries

Valuation and Qualifying Accounts

For the Years Ended December 31, 2020, 2019 and 2018

(in millions)


Col. A	Col. B		Col. C				Col. D		Col. E
			Additions
Description	Balance at Beginning of Period		Charged to Costs and Expenses		Charged to Other Accounts		Deductions		Balance at End of Period
					(a)		(b)
2020:
Allowance for trade receivables	$	35	$	10	$	(1)	$	2	$	42
Allowance for other current receivables	44		1		(1)		2		42
Allowance for long-term receivables	14		1		(3)		—		12
Valuation allowance for deferred taxes	1,243		119		24		109		1,277
	$	1,336	$	131	$	19	$	113	$	1,373
2019:
Allowance for trade receivables	$	40	$	2	$	(4)	$	3	$	35
Allowance for other current receivables	47		(1)		1		3		44
Allowance for long-term receivables	24		—		—		10		14
Valuation allowance for deferred taxes	1,153		349		1		260		1,243
	$	1,264	$	350	$	(2)	$	276	$	1,336
2018:
Allowance for trade receivables	$	50	$	3	$	(6)	$	7	$	40
Allowance for other current receivables	98		(10)		(24)		17		47
Allowance for long-term receivables	21		—		3		—		24
Valuation allowance for deferred taxes	853		409		4		113		1,153
	$	1,022	$	402	$	(23)	$	137	$	1,264

Notes:

(a)Primarily related to divestitures, acquisitions and currency translation.

(b)Represents charges for which allowances were created.

S-1

Previous: Item 15. Exhibits and Financial Statement Schedules.